Assyro AI

FDA Orange Book · active-ingredient family

Demeclocycline hydrochloride

Demeclocycline hydrochloride is approved as 3 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DECLOMYCIN · NDA 050262

3

Brand (NDA)

5

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule, syrup, tablet

ProductApplicantApplicationTEApproved
DECLOMYCINLEDERLENDA 050262Approved Prior to Jan 1, 1982
DECLOMYCINLEDERLENDA 050257Approved Prior to Jan 1, 1982
DECLOMYCIN×3COREPHARMANDA 050261Approved Prior to Jan 1, 1982

Generic (ANDA) products (5)

ProductApplicantApplicationTEApproved
DEMECLOCYCLINE HYDROCHLORIDE×2EPIC PHARMA LLCANDA 065447ABAug 18, 2015
DEMECLOCYCLINE HYDROCHLORIDE×2EPIC PHARMA LLCANDA 065389ABDec 01, 2008
DEMECLOCYCLINE HYDROCHLORIDE×2AMNEAL PHARMANDA 065425ABFeb 27, 2008
DEMECLOCYCLINE HYDROCHLORIDE×2BARRANDA 065171Dec 13, 2004
DEMECLOCYCLINE HYDROCHLORIDE×2IMPAX LABSANDA 065094Mar 22, 2004

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Demeclocycline hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.